Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- WINDMILL CARDIOVASCULAR
- Proposal award date
- 2018-08-06
- Contract end date
- 2019-01-31
- UEI
- DCM2TK5ZRKK6
- Solicitation number
- PA17-302
- Topic code
- NHLBI
Research abstract
Project SummaryAbstract
The goal of this project is to develop high level physiological controlimprove low level dynamic piston controland develop hemodynamic sensing capabilities for the pediatric TORVADTMa unique ventricular assist system
that delivers low shearsynchronouspulsatile flowusing controlled piston motion within a torus shaped
pumping chamberThe pediatric TORVAD is intended for patients with a body surface area fromtombut the design can be scaled to adapt to a wide variety of patient sizes and needsLow shear in the pumped
blood is managed by the relatively low speed of the pistons which are supported by hydrodynamic bearings
that maintain a fixed piston torus gapThe primary operating mode delivers amL counterpulse ejectionbut
the pump can also operate asynchronously to deliver full cardiac support up toL minThe system
synchronizes with the heart to preserve aortic valve flow and maintains autoregulation of cardiac output by the
Frank Starling mechanismThe design of the TORVAD also enables determination of differential pump
pressurewithout additional sensorsThis inherent sensing capability can be used to inform patient
medications and optimal pump supportThese device advantages have been confirmed in benchtop studies
and acute and chronic animal experiments with an adult TORVADand results have indicated preservation of
high molecular weight von Willebrand FactorThe pediatric TORVAD has been designed to exhibit these same
advantagesand thus has the potential to reduce bleedingthrombus formationand strokes that are
associated with the use of other pediatric ventricular assist devicesSpecific aims for Phase I areImprove
the dynamic piston controlImplement dynamic pressure sensing during pump actuationandDevelop
systemic vascular resistanceSVRestimationSpecific aims for Phase II areImplement physiologic
control of VAD flowFabricate devices for acute and chronic animal experimentsPerform four acute
animal studies to assess control algorithmspressure signal sensingand SVR estimationPerform six
chronic animal studies to assess long term viability of the pediatric TORVAD and algorithms Project Narrative
Clinicians are commonly faced with a life sustaining struggle between an increasing need for mechanical
circulatory support in pediatric patients but devices with outcomes that are sub optimalComplications related
to currently available pediatric circulatory support devices are devastatingand serious adverse event rates
associated with these devices are unacceptably highThe pediatric TORVAD has the potential to significantly
reduce the complications associated with ventricular assist devices including the incidence of major bleedingneurological dysfunctionand strokesits success will provide beneficial patient outcomes and allow for more
widespread as well as longer term use of ventricular assist devices in pediatric patients
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
6 SBIR/STTR records share this UEI (2013–2019). Reported award amounts total $6,565,818. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards